S3442
SB 216763
>98% (HPLC), glycogen synthase kinase-3 inhibitor
别名:
3-（2,4-二氯苯基）-4-（1-甲基-1H-吲哚-3-基）-1H-吡咯-2,5-二酮
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C19H12N2O2Cl2
化学文摘社编号:
分子量:
371.22
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
产品名称
SB 216763, >98% (HPLC)
SMILES string
Cn1cc(C2=C(C(=O)NC2=O)c3ccc(Cl)cc3Cl)c4ccccc14
InChI key
JCSGFHVFHSKIJH-UHFFFAOYSA-N
InChI
1S/C19H12Cl2N2O2/c1-23-9-13(11-4-2-3-5-15(11)23)17-16(18(24)22-19(17)25)12-7-6-10(20)8-14(12)21/h2-9H,1H3,(H,22,24,25)
assay
>98% (HPLC)
color
orange
solubility
DMSO: soluble 20 mg/mL
H2O: insoluble
originator
GlaxoSmithKline
storage temp.
−20°C
Quality Level
Gene Information
human ... GSK3A(2931), GSK3B(2932)
Application
使用 SB-216763 抑制人脑微血管内皮细胞系 和大肠癌细胞中的 GSK-3β。
Biochem/physiol Actions
SB-216763 是一种与 ATP 竞争并强效抑制 α和 βGSK-3 的同工酶。作为神经保护剂，它防止 PI3-激酶途径诱导的神经细胞死亡。它还可以延迟预处理，减少梗死面积，防止心肌缺血。
强效、选择性、细胞渗透性糖原合成酶激酶-3 (GSK-3) 抑制剂。
Features and Benefits
该化合物是激酶磷酸酶生物学研究的特色产品。 点击此处 ，发现更多特色激酶磷酸酶生物学产品。前往 sigma.com/discover-bsm 了解更多关于其他研究领域的生物活性小分子。
该化合物由 GlaxoSmithKline 开发。要浏览其他制药公司开发的化合物列表批准的药物/候选药物的列表， 点击这里 。
Legal Information
根据GlaxoSmithKline的协议出售用于研究目的
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
D A Cross et al.
Journal of neurochemistry, 77(1), 94-102 (2001-03-30)
The phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (PKB; also known as Akt) signalling pathway is recognized as playing a central role in the survival of diverse cell types. Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine protein kinase that
Jonathan S Miller et al.
PloS one, 9(2), e88026-e88026 (2014-02-08)
The Akt - GSK3 signaling pathway has been recently implicated in psychostimulant-induced behavioral and cellular effects. Here, the ability of cocaine to regulate the activity of Akt and GSK3 was investigated by measuring the phosphorylation states of the two kinases.
Eric R Gross et al.
American journal of physiology. Heart and circulatory physiology, 294(3), H1497-H1500 (2008-01-29)
Previous studies in our laboratory suggest that an acute inhibition of glycogen synthase kinase 3 (GSK3) by SB-216763 (SB21) is cardioprotective when administered just before reperfusion. However, it is unknown whether the GSK inhibitor SB21 administered 24 h before ischemia
Shuzhen Guo et al.
Stroke, 40(2), 652-655 (2008-11-01)
We recently reported that delayed lithium therapy can improve stroke recovery in rats by augmenting neurovascular remodeling. We tested the hypothesis that lithium can promote the expression of growth factors in brain endothelial cells and astrocytes. Human brain microvascular endothelial
Giulia Rossana Gulino et al.
Environmental health perspectives, 124(6), 776-784 (2015-12-20)
Chrysotile asbestos accounts for > 90% of the asbestos used worldwide, and exposure is associated with asbestosis (asbestos-related fibrosis) and other malignancies; however, the molecular mechanisms involved are not fully understood. A common pathogenic mechanism for these malignancies is represented
商品
Discover Bioactive Small Molecules for Kinase Phosphatase Biology
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持